Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is a publicly traded Healthcare sector company. As of May 21, 2026, RGC trades at $27.39 with a market cap of $13.74B and a P/E ratio of 38.67. RGC moved +3.31% today. Year to date, RGC is +1.29%; over the trailing twelve months it is +131.52%. Its 52-week range spans $0.09 to $83.60. Rallies surfaces RGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate RGC?
The average price target is $0.00.
RGC Key Metrics
Key financial metrics for RGC
Metric
Value
Price
$27.39
Market Cap
$13.74B
P/E Ratio
38.67
EPS
$0.72
Dividend Yield
0.22%
52-Week High
$83.60
52-Week Low
$0.09
Volume
90
Avg Volume
0
Revenue (TTM)
$3.16B
Net Income
$112.30M
Gross Margin
0.00%
RGC Analyst Consensus
RGC analyst coverage data. Average price target: $0.00.
